Sen. Cassidy’s Letters to Drug Manufacturers Welcomed by Drug Industry Trade Group, Draw Skepticism from 340B Provider Advocates

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.
The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Op-Ed Takes Aim at ‘Big Pharma’s’ 340B Program Growth Rhetoric 

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
A major hospital group recently hit back against the drug industry’s claims that hospital behavior has helped drive “out of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: AbbVie Asks 5th Circuit to Reverse Ruling, New Developments in Missouri and Kansas 

Key filings and orders occurred in lawsuits challenging the 340B contract pharmacy access law in Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sen. Welch Hopes His Contract Pharmacy Bill Will Move Soon, ASAP 340B and PhRMA Push for Broader Bill

The Senate version of the 340B PATIENTS Act faces hurdles to passage despite broad support from provider groups.
The sponsor of new Senate legislation that would codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Covered Entities Threaten Action Against Drugmakers Over New Reporting Requirements

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.
A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Welch Introduces 340B PATIENTS Act in the Senate

U.S. Sen. Peter Welch (D-VT) introduced a Senate version of the 340B PATIENTS Act.
A Vermont Democrat has introduced Senate legislation to codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pharma-Linked Watchdog Advocacy Group Leader Pens Op-Ed Urging Congress to Advance 340B Legislation

Tom Schatz, the president of CCAGW and CAGW, urged Congress to "swiftly consider and enact legislation to reform the 340B program” in a Sept. 8 op-ed.
The head of Council for Citizens Against Government Waste (CCAGW)—the lobbying arm of a watchdog group which has long advocated [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Welch Likely to Introduce Senate Version of Matsui’s 340B PATIENTS Act As Soon As Next Week

U.S. Sen. Peter Welch (D-VT) introduced a Senate version of the 340B PATIENTS Act.
A Vermont Democrat and longtime 340B advocate is expected to soon introduce a Senate version of the 340B Pharmaceutical Access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bayer to Extend Contract Pharmacy Restrictions to Federal Grantees, Providers and Advocates Voice Concerns About Recent Trend

Bayer wordmark on side of building
Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Relents on Arkansas Contract Pharmacy Law; AbbVie Exempts MO, MS Covered Entities

Johnson & Johnson building-mounted sign
Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.
Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live